Colin A. McCannel, M.D.
Colin A. McCannel, M.D., F.A.C.S., F.R.C.S.C., is professor of clinical ophthalmology at the Jules Stein Eye Institute, University of California, Los Angeles, and medical director of UCLA’s Stein Eye Center–Santa Monica.
Dr. McCannel specializes in retinal surgery. He received his medical degree from the Mayo Medical School in Rochester, Minnesota. He is a member of the American Society of Retina Surgeons, the Retina Society, the Macula Society, the American Academy of Ophthalmology, California Academy of Eye Physicians and Surgeons, and the American Medical Association. In the past he was a member of the Minnesota Academy of Ophthalmology, where he was also a member of the board of directors and past president.
Dr. McCannel’s clinical interests include surgical and medical diseases of the retina, macula and vitreous, including diabetic retinopathy, macular hole, retinal detachment, complex retinal detachment, epimacular membrane (epiretinal membrane, macular pucker), and age-related macular degeneration. He has lectured worldwide and is a reviewer for several prestigious journals, including the Archives of Ophthalmology, Ophthalmology, and the American Journal of Ophthalmology. He is also a leader in the field of the use of virtual reality simulation technology for ophthalmic surgical teaching.
Latest by Colin A. McCannel, M.D.
A Bionic Eye Implant for AMD?
Research on a bionic eye is underway, which could conceivably offer hope for improved vision in people with dry AMD.
Why AMD Can Lead to Depression
Depression is common in people with age-related macular degeneration—the leading cause of vision loss in older adults. Here’s what to know.
New Ways to Treat Glaucoma
Because untreated glaucoma can cause permanent blindness, research is a major priority. Here’s what’s on the horizon.
Can Cataract Surgery Improve Mental Function?
As people age, problems with vision, such as cataracts, and mental functioning often occur together. Might correcting one improve the other?
Wet AMD Drugs: Positive Results After 5 Years
After five years of drug treatment, about half of people with wet age-related macular degeneration had vision good enough to drive or to read standard print.
Dry AMD Patients Get Help from Statins
Age-related macular degeneration and cardiovascular disease share multiple risk factors, which suggests that therapies that work for one may benefit the other.
Is Aspirin Safe if You Have Wet AMD?
If you have wet age-related macular degeneration you may be worried about taking daily aspirin because of bleeding. Here’s what the latest research says.
Surprising Health Risks of Driving
If you’re frequently behind the wheel, here’s how to reduce your risk of skin cancer and cataracts.
6 Things That Raise Your Risk for Cataracts
Cataracts can occur at any age, but they are most common later in life. More than 20 million Americans over age 40 are estimated to have had one. That number is anticipated to reach about 30 million by 2020. Here are six factors that increase your ri...
Cataract Surgery: What to Expect
Healing may involve eye discomfort or pain. Here’s what you need to know.